Status:
RECRUITING
Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection
Lead Sponsor:
University Health Network, Toronto
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Although chest wall recurrence of breast cancer is uncommon, it represents a difficult clinical scenario. The role of full thickness chest wall resection (FTCWR) for breast cancer recurrence in the ch...
Detailed Description
This study is a prospective, non-randomized cohort study for patients with chest wall-recurrent/invasive breast cancer treated with full thickness chest wall resection (FTCWR), chemotherapy and/or rad...
Eligibility Criteria
Inclusion
- \>18 years of age
- Breast cancer with invasion of the chest wall (ribs, para-costal soft tissue, intercostal muscle or soft-tissue) that is:
- Radiologically proven on cross-sectional imaging
- Histologically proven
- Medically fit for surgery
- \>1 year disease-free interval (between initial treatment and recurrence) for patients with local recurrence
Exclusion
- Medically inoperable due to co-morbidity or other contraindication to surgery
- Technically unresectable disease
- Ineligible for chemotherapy
- ECOG performance status \>2
- Patient refusal
Key Trial Info
Start Date :
August 22 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 22 2030
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03265379
Start Date
August 22 2017
End Date
August 22 2030
Last Update
December 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network (Toronto General Hospital and Princess Margaret Cancer Centre)
Toronto, Ontario, Canada, M5G 2C4